Increased levels of leptin and IGF-1 may serve as potential plasma biomarkers of elevated fetal adiposity, which can predispose individuals to infant obesity and metabolic dysfunction later in life. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.